True combination therapy using synergistic drug combination

Journal of Controlled Release

Volumn 187, Issue , 2014, Pages 198-

  Park, Kinam ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; LIPOSOME; PACLITAXEL; POLYGLUTAMIC ACID; POLYMER; DRUG COMBINATION;

CANCER THERAPY; DRUG COMBINATION; DRUG POTENTIATION; MONOTHERAPY; NOTE; PRIORITY JOURNAL; CHEMISTRY; METABOLISM; NEOPLASM;

ANTINEOPLASTIC AGENTS; DRUG COMBINATIONS; DRUG SYNERGISM; NEOPLASMS; POLYMERS;

EID: 84903535945     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.06.034     Document Type: Editorial

References (4)

1. E. Markovsky, H. Baabur-Cohen, A. Eldar-Boock, L. Omer, G. Tiram, S. Ferber, P. Ofek, D. Polyak, A. Scomparin, and R. Satchi-Fainaro Administration, distribution, metabolism and elimination of polymer therapeutics J. Control. Release 161 2012 446 460
2. F. Kratz, and A. Warnecke Finding the optimal balance: challenges of improving conventional cancer chemotherapy using suitable combinations with nano-sized drug delivery systems J. Control. Release 164 2012 221 235
3. E. Markovsky, H. Baabur-Cohen, and R. Satchi-Fainaro Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs J. Control. Release 187 2014 145 157
4. R. Duncan, and M.J. Vicent Polymer therapeutics-prospects for 21st century: the end of the beginning Adv. Drug Deliv. Rev. 65 2013 60 70